This article is sponsored by SGS. Join SGS’s Health Science team at booth 5D82 to explore their integrated drug development solutions, from analytical testing to clinical research, formulation and manufacturing development. SGS is excited to announce its participation as an exhibitor where it will present its… Read More
This is the latest episode of the free DDW narrated podcast, titled “What trends will speed up the journey from clinic to bedside?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Sitting down with… PharmEnable, Is single-cell… Read More
Contract development and manufacturing organisation (CDMO) uBriGene is expanding into the US market with the acquisition of a manufacturing facility from Mustang Bio. The cell & gene therapy (CGT) CDMO has an established global footprint with two GMP manufacturing facilities in China and its headquarters in… Read More
Listen to this article on the DDW podcast: Samsung Biologics’ Senior Vice President, James Park, explores the opportunities emerging for CDMOs to support mRNA developers as they explore new therapeutic areas for patients. Prior to the pandemic, messenger RNA (mRNA) drug development… Read More
In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring. Many biotech and pharmaceutical companies now rely on contract research organisations (CROs) for drug discovery services. CROs offer an established infrastructure to develop, initiate, execute,… Read More
